180 Life Sciences Expands Ethereum Holdings and Strategic Initiatives

According to PANews, 180 Life Sciences, also known as ETHZilla, has announced its current holdings of 82,186 Ethereum (ETH), acquired at an average price of $3,806.71 per ETH, with a total market value of approximately $349 million. Additionally, the company holds around $238 million in cash equivalents. ETHZilla plans to retain its newly acquired ETH for the long term and aims to generate returns through staking, utilizing a proprietary Ethereum network strategy in collaboration with Electric Capital. The company is accelerating its transformation into an institutional-grade Ethereum reserve management platform while continuing to advance its gaming and biotechnology-related ventures.